Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)

HIV/HCV infection is supposed to substantially reduce survival as compared to HIV mono-infection. Here, we compared longtime-survival and causes of death in a cohort of HIV- and HIV/HCV-co-infected patients on combined antiretroviral therapy (cART), before introduction of HCV direct acting antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales: Dold, L., Schwarze-Zander, C., Boesecke, C., Mohr, R., Langhans, B., Wasmuth, J.-C., Strassburg, C. P., Rockstroh, J. K., Spengler, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715635/
https://www.ncbi.nlm.nih.gov/pubmed/31467319
http://dx.doi.org/10.1038/s41598-019-48756-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715635/
https://www.ncbi.nlm.nih.gov/pubmed/31467319
http://dx.doi.org/10.1038/s41598-019-48756-3

Ejemplares similares